PreciseDx Company
PreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology.
Estimated Revenue:
$1M to $10M
Funding Status:
Early Stage Venture
Industry:
Medical BioTech
Investors Number:
4.0
Last Funding Date:
2022-01-11
Technology:
['BioTech & HealthTech']
Founded Date:
2019-01-01
Headquarters:
New York, New York, United States
Total Funding:
10750000.0
Last Funding Type:
Series A
Employee Number:
45200